Where a cheap medicine is not the same as a generic medicine: The Belgian case

Journal of Pharmaceutical Health Services Research

Volumn 2, Issue 3, 2011, Pages 185-189

  Dylst, Pieter ^a   Vulto, Arnold ^b   Simoens, Steven ^a  

^a Research Centre for Pharmaceutical Care and Pharmaco Economics   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Belgium; Cheap medicines; Generic medicines; Prescribing behaviour; Prescribing limits

Indexed keywords

GENERIC DRUG;

AMBULATORY CARE; ARTICLE; BELGIUM; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG QUALITY; POLICY; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 80051803623     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2011.00061.x     Document Type: Article

References (20)

1. World Health Organization. European Health for All Database (HFA-DB), WHO/Europe. Brussels: World Health Organization, 2011. (accessed 22 March 2011).
2. Organisation for Economic Co-operation and Development. Health at a Glance: Europe 2010. Paris: Organisation for Economic Co-operation and Development, 2010.
3. st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union 2004; L136: 34-57. (accessed 22 March 2011).
4. Simoens S, De Coster S. Sustaining Generic Medicines Markets in Europe. Leuven: Katholieke Universiteit Leuven, 2006. (accessed 22 March 2011).
5. Vogler S, Schmickl B. Rational Use of Medicines in Europe. Vienna: Österreichisches Bundesinstitut fur Gesundheitswesen, 2010.
6. Mossialos E etal. Provider incentives and prescribing behavior in Europe. Expert Rev Pharmacoecon Outcomes Res 2005; 5: 91-93.
7. European Generic Medicines Association. How to Increase Patient Access to Generic Medicines in European Healthcare Systems. Brussels: European Generic Medicines Association, 2009. (accessed 22 March 2011).
8. Simoens S etal. Pharmaceutical policy regarding generic drugs in Belgium. Pharmacoeconomics 2005; 23: 755-766.
9. th December 1997. Brussels: Belgian Federal Parliament, 1997.
10. th September 2005. Brussels: Belgian Federal Parliament, 2005.
11. th September 2005. Brussels: Belgian Federal Parliament, 2005.
12. World Health Organization Collaborating Centre for Drug Statistics and Methodology. DDD: Definition and General Considerations. Oslo: World Health Organization Collaborating Centre for Drug Statistics and Methodology [online], 2011. (accessed 22 March 2011).
13. RIZIV/INAMI. Feedbacks: Minimum Prescribing of Cheap Medicines. Brussels: RIZIV/INAMI, 2011. (accessed 22 March 2011).
14. Pharma.be. Press release (5 November 2009). Brussels: Pharma.be [website]. (accessed 21 March 2011).
15. RIZIV/INAMI. Pharmaceutical Statistics, Pharmaceutical Service, Ambulatory Care 2008. Brussels: RIZIV/INAMI, 2008. (accessed 21 March 2011).
16. Vrijens F etal. Report No.: 126A: The Reference Price System and Socio-Economic Disparities in the Use of Cheap Medicines. Brussels: KCE (Belgian Health Care Knowledge Centre), 2010.
17. FeBelGen. Press release (26 October 2010). Wilrijk: FeBelGen [website]. (accessed 23 March 2011).
18. st December 2010. Brussels: Belgian Federal Parliament, 2010.
19. Medistrat. Cost Effective Healthcare: Principal Results. Halle: Medistrat, 2010.
20. European Generic Medicines Association. 2010 Market Review. Brussels: European Generic Medicines Association, 2010.